Clinical Trial Update: CP-461 for the Treatment of Crohn's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial CP-461 for Crohn's disease conducted by Astellas Pharma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• CP-461

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED